Adipose Tissue Dysfunction in Nascent Metabolic Syndrome
Open Access
- 1 January 2013
- journal article
- review article
- Published by Hindawi Limited in Journal of Obesity
- Vol. 2013, 1-8
- https://doi.org/10.1155/2013/393192
Abstract
The metabolic syndrome (MetS) confers an increased risk for both type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). Moreover, studies on adipose tissue biology in nascent MetS uncomplicated by T2DM and/or CVD are scanty. Recently, we demonstrated that adipose tissue dysregulation and aberrant adipokine secretion contribute towards the syndrome’s low-grade chronic proinflammatory state and insulin resistance. Specifically, we have made the novel observation that subcutaneous adipose tissue (SAT) in subjects with nascent MetS has increased macrophage recruitment with cardinal crown-like structures. We have also shown that subjects with nascent MetS have increased the levels of SAT-secreted adipokines (IL-1, IL-6, IL-8, leptin, RBP-4, CRP, SAA, PAI-1, MCP-1, and chemerin) and plasma adipokines (IL-1, IL-6, leptin, RBP-4, CRP, SAA, and chemerin), as well as decreased levels of plasma adiponectin and both plasma and SAT omentin-1. The majority of these abnormalities persisted following correction for increased adiposity. Our data, as well as data from other investigators, thus, highlight the importance of subcutaneous adipose tissue dysfunction in subjects with MetS and its contribution to the proinflammatory state and insulin resistance. This adipokine profile may contribute to increased insulin resistance and low-grade inflammation, promoting the increased risk of T2DM and CVD.Keywords
Funding Information
- American Diabetes Association (KL2 RR024144, UL1 RR024146)
This publication has 60 references indexed in Scilit:
- Adipose Tissue Dysregulation in Patients with Metabolic SyndromeJournal of Clinical Endocrinology & Metabolism, 2011
- Adipokines as novel biomarkers and regulators of the metabolic syndromeAnnals of the New York Academy of Sciences, 2010
- Chemerin: at the crossroads of inflammation and obesityTrends in Endocrinology & Metabolism, 2010
- Chronic Inflammation in Obesity and the Metabolic SyndromeMediators of Inflammation, 2010
- Adipose tissue recruitment of leukocytesCurrent Opinion in Lipidology, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Chemerin Is Associated with Metabolic Syndrome Phenotypes in a Mexican-American PopulationJournal of Clinical Endocrinology & Metabolism, 2009
- Adipose Macrophage Infiltration Is Associated With Insulin Resistance and Vascular Endothelial Dysfunction in Obese SubjectsArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Inflammation and metabolic disordersNature, 2006
- Is visceral obesity the cause of the metabolic syndrome?Annals of Medicine, 2006